Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MSI Methylation Sciences
company
About
MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- €13.50M
- Industries
- Biotechnology,Dietary Supplements,Medical,Therapeutics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 51 - 100
- Operating Status
- Active
MSI Methylation Sciences Inc. operates as a biotechnology company. The company develops and markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. MSI Methylation Sciences Inc. was founded in 2007 and is based in West Vancouver, Canada.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€13.50M
MSI Methylation Sciences has raised a total of
€13.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 29, 2011 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 29, 2011 | Series A | €13.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
MSI Methylation Sciences is funded by 1 investors.
Working Opportunity Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Working Opportunity Fund
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
